-transparent.png){kind=logo}
Eighty-nine pediatric patients admitted at the University of Santo Tomas Hospital from June to December 1992, with the clinical diagnosis of dengue hemorrhagic fever (DHF) were studied with the following objectives: To determine the possible use of hematocrit, platelet count, prothrombin time (PT) and partial thromboplastin time (PTT) as predictors of bleeding and outcome in patient with DHF. The following were established: PTT can be an index in predicting bleeding in DHF. The tendency to bleed is greater with prolongation of > 30 seconds; platelet count can be a predictor of mortality, with death six times greater among those platelet count < 50,000/microliters than those whose platelet count was > 50,000/microliters. PT can also predict bleeding in patients with DHF.
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
February 1986,
Emergency medicine clinics of North America,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
December 1997,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
May 1992,
New Jersey medicine : the journal of the Medical Society of New Jersey,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
April 1998,
Der Anaesthesist,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
April 1982,
Southern medical journal,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
May 2020,
The American journal of tropical medicine and hygiene,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
June 2009,
Clinics in laboratory medicine,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
October 1970,
Revista medica de Chile,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
November 1970,
JAMA,
M N Chua, and
R Molanida, and
M de Guzman, and
F Laberiza
January 1999,
Transfusion,
